Nevro Corp. (NVRO)
Chart Events
Performance Outlook
| Previous Close | 148.35 |
| Open | 148.30 |
| Bid | 154.09 x 900 |
| Ask | 154.17 x 800 |
| Day's Range | 148.56 - 155.80 |
| 52 Week Range | 99.49 - 188.14 |
| Volume | 509,889 |
| Avg. Volume | 436,158 |
| Market Cap | 5.363B |
| Beta (5Y Monthly) | 0.99 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.47 |
| Earnings Date | Apr 07, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 199.08 |
- Insider Monkey
Here’s Why Nevro Corp. (NVRO) Landed in Alger Weatherbie’s Top Detractor List
Alger, an investment management firm, published its “Alger Weatherbie Specialized Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. During the quarter, the largest portfolio sector weightings were Information Technology and Health Care. The largest sector overweight was Financials. Class A shares of the Alger Weatherbie Specialized Growth […]
- PR Newswire
Nevro Appoints Jon R. Shear as Vice President, Corporate Development
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointment of Jon Shear to the newly created position of Vice President, Corporate Development, effective immediately.
- Insider Monkey
Is NVRO Stock A Buy or Sell?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31st. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […]
